• Joan Rothchild Hardin

BIMUNO – Prebiotics for Anxiety, OCD, Depression & Overall Health

I was looking for a non-pharmaceutical way to help my anxious and OCD patients so asked my supplements guru, David Miller, MD at LifeThyme (a health food store in NYC). He sent information about a new PREbiotic supplement that’s been demonstrated to be helpful for anxiety and OCD thinking – and the entire immune system located in the gut microbiome. It’s called Bimuno®. (Miller, 2015) Bimuno® isn’t readily available yet in the US but can be ordered from the company’s website in England. Research on it and the information on the company’s site are very interesting. It comes as sachets of tasteless powder to sprinkle over food or add to drinks and also as soft chewable pastilles. I just ordered some (the pastilles) to try myself – especially to use during travels outside the country, which often lead to upsets in my gut microbiome.

Bimuno® is a new PREbiotic product that feeds the good, PRObiotic bacteria living in our guts (such as Lactobacilli and Bifidobacteria) to the detriment of the bad bacteria (pathogens). As the good bacteria multiply, they flush out the bad bacteria. WHAT COULD BE BETTER!?


PREBIOTICS are specialized plant fibers containing complex sugars (such as inulin,  fructo-ogliosaccharides and galacto-oligosaccharides) that are indigestible by humans but promote the growth of beneficial bacteria (PROBIOTICS) living in our gut microbiomes by serving as food for them. PROBIOTICS are helpful, live bacteria and yeasts our bodies need to function and maintain good health. They are found in fermented foods such as kefir, live-culture yogurt, real sauerkraut and pickles (not ones made with vinegar), kimchi, kombucha and other naturally fermented foods. If our gut flora has already become seriously out of balance, we can also benefit from taking high quality probiotics as supplements to populate the necessary array of friendly bacteria in our gut microbiomes. There are hundreds of probiotic species living in the human gut – some that are known to be ancient life forms and many that scientists haven’t even been able to identify yet. Sometimes PREBIOTICS and PROBIOTICS are combined in the same supplements, called SYNBIOTICS. See my earlier posts Prebiotics and Probiotics and  PREbiotics and PREbiotics for more information.

SCIENTIFIC BASIS FOR THIS PREBIOTIC PRODUCT’S EFFICACY From the Bimuno® website: Scientific studies have demonstrated that Bimuno can significantly increase levels of Bifidobacteria (good bacteria) in the gut.1 Bimuno is the only second generation Galacto-oligosaccharide prebiotic available. It is a truly unique prebiotic with a powerful Bifidogenic effect. Bimuno’s unique galacto-oligosaccharide structure It selectively boosts Bifidobacteria which play a key role in immune function and maintaining and building a healthy digestive system. Bimuno is the result of many years of intensive research by a team of international digestive health experts and the University of Reading. A number of clinical trials have been published and there is an ongoing research and development program into Bimuno across a number of health areas including:

  • The Immune system

  • Various aspects of digestive Health

  • Digestive health while abroad

  • Various aspects of human metabolism

Reference: 1. Am J Clin Nutr 2008; 87 :785-91 Bimuno® original powder is the natural way to increase and energise your good gut bacteria helping you to manage your gut health.  Bimuno works in a similar way to prebiotics naturally found in human breast milk which promote a healthy bacterial balance within the gut. Scientific studies indicate that the unique second generation Galacto-oligosaccharide formulation of Bimuno powder, can help to encourage and sustain a healthy level of your friendly gut bacteria(Bifidobacteria). In fact Bimuno has the most potent bifidogenic (Bifidobacteria promoting) effect of any available prebiotic. Published scientific studies have shown that, with daily use, the majority of Bimuno users experience a significant increase in their gut Bifidobacterium within just 7 days. This in itself is impressive but by a unique anti-adhesive action it also helps flush ‘bad’ bacteria from your gut at the same time for a healthy microflora balance. Give your digestive system a healthy boost Bimuno powder:

  • Increases your Bifidobacteria levels, helping to maintain a healthy intestinal balance.

  • Reduces gas producing bacteria

  • Reduces bad bacteria levels

  • Energises your friendly gut bacteria

  • By maintaining a healthy digestive balance you can support overall well-being

GUT DYSBIOSIS AND ANXIETY Christian John Lillis, of the Peggy Lillis Foundation, reports noticing an uptick in the number of people on Clostridium difficile Facebook groups who mention that they’re also struggling with anxiety. (Lillis, 2015) This overlap between C. diff (a serious bacterial infection of the colon) and anxiety isn’t at all surprising. An out of balance (dysbiotic) gut microbiome produces a wide variety of symptoms – including anxiety, depression, and OCD.

Animal studies have previously shown a link between mood and brain function and probiotics in the gut microbiota. Ingestion of Lactobacillus rhamnosus (a strain of PRObiotic) has been demonstrated to modulate information processing strongly linked to anxiety and depression and to improve the neuro-endocrine stress response in lab animals – in plain English, this probiotic turned anxious, fearful mice into mellow ones. Now new research on healthy human adults conducted by a group of neurobiologists at Oxford University demonstrated that supplementation with PREbiotics (Bimuno® galacto-oligosaccharides, B-GOS) lowered the subjects’ neuro-endocrine stress responses and increased their ability to  process positive versus negative attentional vigilance. In other words, PREbiotic supplementation with Bimuno REDUCED THEIR ANXIETY LEVELS AND OCD THINKING. The researchers assessed how subjects processed emotional information, such as positively and negatively charged words, after they’d been taking the prebiotic supplement. Results showed that the supplemented group paid less attention to negative information and more attention to positive information than either a group given another type of prebiotic (fructooligosaccharides, FOS) or a group given a placebo. The people who had taken Bimuno® also had lower levels of cortisol (a stress hormone linked with anxiety and depression) in their morning saliva. A similar effect has been observed in people taking anti-depressants and anti-anxiety pharmaceutical medication. (Schmidt et al, 2014) (Gregoire, 2015) This is very good news for people suffering from anxiety and OCD. Taking a prebiotic supplement may relieve their life-impinging symptoms while also improving their overall physical health – without the adverse effects of pharmaceuticals.

BIMUNO‘S INGREDIENTS Information listed on the box of Bimuno powder sachets:

  • Galacto-oligosaccharides (GOS)

  • Lactose (from milk)

  • Glucose syrup

  • Thickener (gum arabic)

  • Galactose

  • Acidity regulator (trisodium citrate)

  • Free from artificial colors, flavours and preservatives

  • Gluten-free

  • 16 Cal/sachet

The galacto-oligosaccharides in Bimuno® are a mixture of disaccharides, trisaccharides, a tetrasaccharide and a pentasaccharide. THE BIMUNO WEBSITE I recommend checking out the Bimuno website. The pull down menus are chock full of useful and fascinating information about digestive and whole body health, prebiotics/ probiotics and the immune system. See the information under:

  • Maintain your digestive health

  • Digestive problems & solutions

  • Support your immune defences

  • Digestive health for traveling

REFERENCES Bimuno. (2015). Bimuno’s website. See: Depeint, F. et al. (2008). Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity ofBifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. See: Gregoire, C. (2015). The Surprising Link Between Gut Bacteria And Anxiety. The Huffington Post. See: Hardin, J.R. (2013). Probiotics and Probiotics. See:

Lillis, J.C. (2015). Private communication. Miller, D. (2015). Private communication. Schmidt, K. (2014). Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. See: Vulevic, J. et al. (2008). Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. See: © Copyright 2015 Joan Rothchild Hardin. All Rights Reserved.

DISCLAIMER:  Nothing on this site or blog is intended to provide medical advice, diagnosis or treatment.

Comments submitted prior to 8/25/2021

Or…just eat prebiotic foods.

They do the exact same thing. In general I am wary of websites that present research about their specific product as being helpful without presenting other studies comparing to other companies products or to levels in known other

sources of the stuff. And without careful control of other variables, etc.

Ok. Prebiotcs are great, but why those particular ones? Why promote this and not the consumption of well know prebiotic foods? Who sponsored the studies? How many of those are peer reviewd? I would have no less requirements of proof of scientific results for reportedly natural stuff that I would for other stuff.

Just saying. I can get my prebiotics in the foods I eat.

Na’ama Yehuda

In reply to Na'ama.Na’ama,

The article you site mentions three types of prebiotics occurring naturally in foods: Inulins, Fructo-oligosaccharides (FOS), and Galacto-oligosaccharides (GOS). The research that led to the development of Bimuno demonstrated only Galacto-oligosaccharides (GOS) to be useful in reducing anxiety levels and OCD thinking in the study’s subjects. Fructo-oligosaccharides (FOS) were no more helpful than a placebo. Inulins apparently weren’t included in this research. Here’s a list of research studies that led to the development of

Bimuno with the particular type of galacto-oligosaccharides found in it.

Joan Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine

Savignaca, Coronab, Millsa, Chena, Spencerb, Tzortzisc, & Burneta Neurochemistry International. Volume 63, Issue 8, December 2013, Pages 756–764 Conclusion

Our results have provided the necessary ‘proof-of-principle’ for the central actions of prebiotic consumption. The increase of hippocampal BDNF after prebiotic intake is consistent with a probiotic effect, and may have been a direct consequence of elevated gut Bifidobacteria

numbers. However, an additional effect of gut hormones (e.g. PYY) or other mediators, such as the immune system resulting from direct oligosaccharide-gut interactions, cannot be ruled out. The elevation of NMDAR subunits after prebiotics is intuitive given their reduction in

the brains of germ-free animals. Furthermore, the strong correlation between Bifidobacteria numbers and cortical NR1 levels presented in this report, further supports a link between the microbiota and central glutamate neurotransmission. Mechanistic investigations beyond the scope of the present study, are now required to ascertain the systems underlying the observed changes, and will also reveal if vagal nerve modulation is involved. Moreover, behavioural analysis in rats will ascertain if the changes in BDNF after prebiotics impart an anxiolytic action, or that increased NMDAR subunits translate to improved cognitive

performance. Importantly, our study has provided sufficient cause to warrant further exploration into the utility of prebiotics in therapies of neuropsychiatric illness and which, by virtue of their ability to proliferate gut bacteria and stimulate neuroendocrine (and other)

responses, may even prove to be more potent than probiotics.


J.C. Anthony, T.N. Merriman, J.T. Heimbach

90-Day oral (gavage) study in rats with galacto-oligosaccharides syrup

Food Chem. Toxicol., 44 (6) (2006), pp. 819–826

P. Bercik, E. Denou, J. Collins, W. Jackson, J. Lu, J. Jury, Y. Deng,

P. Blennerhassett, J. Macri, K.D. McCoy, E.F. Verdu, S.M. Collins

The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice

Gastroenterology, 141 (2011), pp. 599–609

P. Bercik, A.J. Park, D. Sinclair, A. Khoshdel, J. Lu, X. Huang, Y.

Deng, P.A. Blennerhassett, M. Fahnestock, D. Moine, B. Berger, J.D.

Huizinga, W. Kunze, P.G. McLean, G.E. Bergonzelli, S.M. Collins, E.F.


The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication

Neurogastroenterol. Motil., 23 (2011), pp. 1132–1139

L. Bode, C. Kunz, M. Muhly-Reinholz, K. Mayer, W. Seeger, S. Rudloff

Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides

Thromb. Haemost., 92 (2004), pp. 1402–1410

W. Boesmans, P. Gomes, J. Janssens, J. Tack, P. Vanden Berghe

Brain-derived neurotrophic factor amplifies neurotransmitter responses

and promotes synaptic communication in the enteric nervous system

Gut, 57 (2008), pp. 314–322

J.A. Bravo, P. Forsythe, M.V. Chew, E. Escaravage, H.M. Savignac, T.G. Dinan, J. Bienenstock, J.F. Cryan

Ingestion of Lactobacillus strain regulates emotional behavior and

central GABA receptor expression in a mouse via the vagus nerve

Proc. Natl. Acad. Sci. USA, 108 (38) (2011), pp. 16050–16055

P.W. Burnet, P.N. Anderson, L. Chen, N. Nikiforova, P.J. Harrison, M.J. Wood

D-amino acid oxidase knockdown in the mouse cerebellum reduces NR2A mRNA

Mol. Cell. Neurosci., 46 (2011), pp. 167–175

P.W. Burnet

Gut bacteria and brain function: the challenges of a growing field

Proc. Natl. Acad. Sci. USA, 109 (2012), p. E175

C. Chiaruttini, M. Sonego, G. Baj, M. Simonato, E. Tongiorgi

BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae

Mol. Cell. Neurosci., 37 (2008), pp. 11–19

M. Coco, S. Caggia, G. Musumeci, V. Perciavalle, A.C. Graziano, G. Pannuzzo, V. Cardile

Sodium L-lactate differently affects brain-derived neurotrophic factor,

inducible nitric oxide synthase, and heat shock protein 70 kDa

production in human astrocytes and SH-SY5Y cultures

J. Neurosci. Res., 91 (2) (2013), pp. 313–320

G.L. Collingridge, A. Volianskis, N. Bannister, G. France, L. Hanna,

M. Mercier, P. Tidball, G. Fang, M.W. Irvine, B.M. Costa, D.T. Monaghan,

Z.A. Bortolotto, E. Molnár, D. Lodge, D.E. Jane

The NMDA receptor as a target for cognitive enhancement

Neuropharmacology, 64 (1) (2013), pp. 13–26

M. Connor, A. Yeo, G. Henderson

Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to

mobilization of intracellular calcium in SH-SY5Y human neuroblastoma


Br. J. Pharmacol., 120 (1997), pp. 455–463

J.F. Cryan, T.G. Dinan

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Nat. Rev. Neurosci., 13 (2012), pp. 701–712

E. Delmée, P.D. Cani, G. Gual, C. Knauf, R. Burcelin, N. Maton, N.M. Delzenne

Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice

Life Sci., 79 (2006), pp. 1007–101

Drakoularakou, G. Tzortzis, R.A. Rastall, G.R. Gibson

A double-blind, placebo-controlled, randomized human study assessing the

capacity of a novel galacto-oligosaccharide mixture in reducing

travellers’ diarrhoea

Eur. J. Clin. Nutr., 64 (2010), pp. 146–152

S.L. Eastwood, B. McDonald, P.W. Burnet, J.P. Beckwith, R.W. Kerwin, P.J. Harrison

Decreased expression of mRNAs encoding non-NMDA glutamate receptors

GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

Brain Res. Mol. Brain Res., 29 (1995), pp. 211–223

T. Eiwegger, B. Stahl, P. Haidl, J. Schmitt, G. Boehm, E. Dehlink, R. Urbanek, Z. Szépfalusi

Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties

Pediatr. Allergy Immunol., 21 (2010), pp. 1179–1188

P. Forsythe, W.A. Kunze

Voices from within: gut microbes and the CNS

Cell. Mol. Life Sci., 70 (2012), pp. 55–69 PMID:22638926

S.L. Grant, Y. Shulman, P. Tibbo, et al.

Determination of D-serine and related neuroactive amino acids in human

plasma by high-performance liquid chromatography with fluorimetric


J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 844 (2006), pp. 278–282

E.J. Hernandez, D.C. Whitcomb, S.R. Vigna, I.L. Taylor

Saturable binding of circulating peptide YY in the dorsal vagal complex of rats

Am. J. Physiol., 266 (1994), pp. G511–G516

G. Jakobsdottir, C. Jädert, L. Holm, M.E. Nyman

Propionic and butyric acids, formed in the caecum of rats fed highly

fermentable dietary fibre, are reflected in portal and aortic serum

Br. J. Nutr., 26 (2013), pp. 1–8

T. Kato, H. Funakoshi, K. Kadoyama, S. Noma, M. Kanai, W. Ohya-Shimada, S. Mizuno, N. Doe, T. Taniguchi, T. Nakamura

Hepatocyte growth factor overexpression in the nervous system enhances learning and memory performance in mice

J. Neurosci. Res., 90 (2012), pp. 1743–1755

I.A. Kerman

New insights into BDNF signalling: relevance to major depression and antidepressant action

Am. J. Psychiatry, 169 (2012), pp. 1137–1140

Ketabi, L.A. Dieleman, M.G. Gänzle

Influence of isomalto-oligosaccharides on intestinal microbiota in rats

J. Appl. Microbiol., 110 (2011), pp. 1297–1306

J.P. Kiss, B.K. Szasz, L. Fodor, A. Mike, N. Lenkey, D. Kurkó, J. Nagy, E.S. Vizi

GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine

Neurochem. Int., 60 (2) (2012), pp. 170–176

R. Konno, T. Oowada, A. Ozaki, T. Iida, A. Niwa, Y. Yasumura, T. Mizutani

Origin of D-alanine present in urine of mutant mice lacking D-amino-acid oxidase activity

Am. J. Physiol., 265 (1993), pp. G699–G703

W. Li, S.E. Dowd, B. Scurlock, V. Acosta-Martinez, M. Lyte

Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria

Physiol. Behav., 96 (2009), pp. 557–567

L. Liu, T.P. Wong, M.F. Pozza, K. Lingenhoehl, Y. Wang, M. Sheng, Y.P. Auberson, Y.T. Wang

Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity

Science, 304 (2004), pp. 1021–1024

M. Messaoudi, R. Lalonde, N. Violle, H. Javelot, D. Desor, A. Nejdi,

J.F. Bisson, C. Rougeot, M. Pichelin, M. Cazaubiel, J.M. Cazaubiel

Assessment of psychotropic-like properties of a probiotic formulation

(Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in

rats and human subjects

Br. J. Nutr., 105 (5) (2011), pp. 755–764

M. Messaoudi, N. Violle, J.F. Bisson, D. Desor, H. Javelot, C. Rougeot

Beneficial psychological effects of a probiotic formulation

(Lactobacillus helveticus R0052 andBifidobacterium longum R0175) in

healthy human volunteers

Gut Microbes, 2 (4) (2011), pp. 256–261

Morikawa, K. Hamase, T. Inoue, R. Konno, A. Niwa, K. Zaitsu

Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity

J. Chromatogr. B Biomed. Sci. Appl., 757 (2001), pp. 119–125

Morikawa, K. Hamase, T. Inoue, R. Konno, K. Zaitsu

Alterations in D-amino acid levels in the brains of mice and rats after the administration of D-amino acids

Amino Acids, 32 (2007), pp. 13–20

M.C. Murphy, E.A. Fox

Mice deficient in brain-derived neurotrophic factor have altered development of gastric vagal sensory innervation

J. Comp. Neurol., 518 (2010), pp. 2934–2951

K.M. Neufeld, N. Kang, J. Bienenstock, J.A. Foster

Reduced anxiety-like behavior and central neurochemical change in germ-free mice

Neurogastroenterol. Motil., 223 (3) (2011), pp. 255–264

N. Nonaka, S. Shioda, M.L. Niehoff, W.A. Banks

Characterization of blood–brain barrier permeability to PYY3-36 in the mouse

J. Pharmacol. Exp. Ther., 306 (2003), pp. 948–953

E. O’Sullivan, E. Barrett, S. Grenham, P. Fitzgerald, C. Stanton, R.P. Ross, E.M. Quigley, J.F. Cryan, T.G. Dinan

BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels?

Benef. Microbes, 2 (3) (2011), pp. 199–207

J. Overduin, M.H. Schoterman, W. Calame, A.J. Schonewille, S.J. Ten Bruggencate

Dietary galacto-oligosaccharides and calcium: effects on energy intake,

fat-pad weight and satiety-related, gastrointestinal hormones in rats

Br. J. Nutr., 31 (2013), pp. 1–11

S. Owczarek, J. Hou, T. Secher, L.V. Kristiansen

Phencyclidine treatment increases NR2A and NR2B N-methyl-D-aspartate receptor subunit expression in rats

Neuroreport, 22 (2011), pp. 935–938

G. Paxinos, C. Watson

The Rat Brain in Stereotaxic Coordinates

Academic Press Inc., San Diego (1986)

A.V. Rao, A.C. Bested, T.M. Beauln

e, M.A. Katzman, C. Iorio, J.M. Berardi, A.C. Logan

A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome

Gut Pathog., 1 (1) (2009), p. 6

D. Rosenberg, E. Kartvelishvily, M. Shleper, C.M. Klinker, M.T. Bowser, H. Wolosker

Neuronal release of D-serine: a physiological pathway controlling extracellular D-serine concentration

FASEB J., 24 (2010), pp. 2951–2961

P. Sikka, R. Walker, R. Cockayne, M.J. Wood, P.J. Harrison, P.W. Burnet

D-Serine metabolism in C6 glioma cells: involvement of

alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR)

but not D-amino acid oxidase (DAO)

J. Neurosci. Res., 88 (2010), pp. 1829–1840

N. Sudo, Y. Chida, Y. Aiba, J. Sonoda, N. Oyama, X.N. Yu, C. Kubo, Y. Koga

Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice

J. Physiol., 558 (Pt. 1) (2004), pp. 263–275

N. van Vlies, A. Hogenkamp, S. Thijssen, G.M. Dingjan, K. Knipping, J. Garssen, L.M. Knippels

Effects of short-chain galacto- and long-chain fructo-oligosaccharides on systemic and local immune status during pregnancy

J. Reprod. Immunol., 94 (2) (2012), pp. 161–168

J. Vulevic, A. Drakoularakou, P. Yaqoob, G. Tzortzis, G.R. Gibson

Modulation of the fecal microflora profile and immune function by a

novel trans-galacto-oligosaccharide mixture (B-GOS) in healthy elderly


Am. J. Clin. Nutr., 88 (2008), pp. 1438–1446

J. Vulevic, A. Juric, G. Tzortzis, G.R. Gibson

A mixture of trans-galacto-oligosaccharides reduces markers of metabolic

syndrome and modulates the fecal microbiota and immune function of

overweight adults

J. Nutr., 143 (3) (2013), pp. 324–331

Sorry, but eating prebiotic foods, while the intention is good, the results don’t equate. You can not eat enough prebiotic fiber to get the recommended amounts of beneficial fiber in diet alone. That is why we prefer Prebiotin prebiotic fiber supplements. Not only does it provide

that beneficial fiber in easy to take powder form, it provides a “full-spectrum” prebiotic benefit, i.e. it feeds both sides of the colon, not just one as with inulin and other prebiotics. Just feed it ! with

Ronald Walborn Jr